| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | AORT | Common Stock | Sale | $160,275 | -5,402 | -6.4% | $29.67 | 79,236 | 25 May 2021 | Direct | F1 |
| transaction | AORT | Common Stock | Sale | $26,135 | -880 | -1.1% | $29.70 | 78,356 | 25 May 2021 | Direct | F2 |
| transaction | AORT | Common Stock | Sale | $191,470 | -6,457 | -8.2% | $29.65 | 71,899 | 25 May 2021 | Direct | F3 |
| transaction | AORT | Common Stock | Options Exercise | $141,748 | +5,402 | +6.8% | $26.24 | 84,638 | 25 May 2021 | Direct |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | AORT | Stock Options (Right To buy) | Options Exercise | $141,748 | -5,402 | -100% | $26.24 | 0 | 25 May 2021 | Common Stock | 5,402 | $26.24 | Direct | F4 |
| Id | Content |
|---|---|
| F1 | Reflects weighted average price. Range of prices were between $29.47 to $30.14. The reporting person will provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. |
| F2 | Reflects weighted average price. Range of prices were between $29.47 to $30.04. The reporting person will provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. |
| F3 | Reflects weighted average price. Range of prices were between $29.44 to $30.135. The reporting person will provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. |
| F4 | Stock option vests 33 1/3% per year beginning on the first anniversary of the grant date. The first exercisable date was 2/19/2021 |